XML 17 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 30, 2019
Mar. 31, 2018
Operating Activities    
Net Income Attributable to Kadant $ 10,900 $ 10,858
Net income attributable to noncontrolling interest 165 150
Net income 11,065 11,008
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 8,231 6,099
Stock-based compensation expense 1,553 1,464
Right-of-use asset amortization 1,083 0
Provision for losses on accounts receivable 64 316
(Gain) loss on the sale of property, plant, and equipment (200) 24
Other items, net (487) (386)
Changes in current assets and liabilities, net of effects of acquisitions:    
Accounts receivable (1,190) (799)
Unbilled revenues (1,055) 2,064
Inventories (3,263) (9,674)
Other current assets (189) (435)
Accounts payable 3,872 3,854
Other current liabilities (9,608) (6,319)
Net cash provided by operating activities 9,876 7,216
Investing Activities    
Acquisition, net of cash acquired (Note 2) (175,288) 0
Purchases of property, plant, and equipment (2,168) (5,151)
Proceeds from sale of property, plant, and equipment 293 28
Net cash used in investing activities (177,163) (5,123)
Financing Activities    
Proceeds from issuance of long-term obligations 189,000 12,000
Repayment of long-term obligations (6,404) (13,493)
Tax withholding payments related to stock-based compensation (2,647) (3,641)
Dividends paid (2,444) (2,316)
Proceeds from issuance of Company common stock 723 742
Payment of debt issuance costs (36) 0
Net cash provided by (used in) financing activities 178,192 (6,708)
Exchange Rate Effect on Cash, Cash Equivalents, and Restricted Cash 153 1,511
Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash 11,058 (3,104)
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period 46,117 76,846
Cash, Cash Equivalents, and Restricted Cash at End of Period $ 57,175 $ 73,742